应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SPRO Spero Therapeutics Inc.
休市中 12-20 15:59:59 EST
0.9551
-0.0429
-4.30%
盘后
0.9551
+0.0000
0.00%
18:37 EST
最高
0.9900
最低
0.9501
成交量
32.96万
今开
0.9900
昨收
0.9980
日振幅
4.00%
总市值
5,207万
流通市值
3,906万
总股本
5,452万
成交额
31.97万
换手率
0.81%
流通股本
4,090万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.17%
市场透视 · 11-25
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.17%
Spero Therapeutics, Inc.2024财年第三财季实现净利润-17.15百万美元,同比减少434.27%
市场透视 · 11-23
Spero Therapeutics, Inc.2024财年第三财季实现净利润-17.15百万美元,同比减少434.27%
Spero Therapeutics, Inc.盘中异动 快速上涨5.12%
市场透视 · 11-21
Spero Therapeutics, Inc.盘中异动 快速上涨5.12%
Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%
市场透视 · 11-19
Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%
Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元
市场透视 · 11-15
Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元
Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻
Reuters · 11-08
Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元
市场透视 · 11-04
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元
Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元
市场透视 · 10-31
Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元
Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元
市场透视 · 10-30
Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元
Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元
市场透视 · 10-26
Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%
市场透视 · 10-18
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%
Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%
市场透视 · 10-08
Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%
Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元
市场透视 · 09-27
Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元
Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元
自选股智能写手 · 08-19
Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元
Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%
自选股智能写手 · 08-12
Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%
TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。
智通财经 · 08-07
TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元
自选股智能写手 · 08-06
Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元
自选股智能写手 · 07-26
Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元
Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%
自选股智能写手 · 07-19
Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%
Spero Therapeutics, Inc.盘中异动 股价大涨5.19%
自选股智能写手 · 07-17
Spero Therapeutics, Inc.盘中异动 股价大涨5.19%
加载更多
公司概况
公司名称:
Spero Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,该公司相信这将开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。该公司相信,如果成功地开发和批准该新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。
发行价格:
--
{"stockData":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":0.9551,"timestamp":1734728399999,"preClose":0.998,"halted":0,"volume":329607,"hourTrading":{"tag":"盘后","latestPrice":0.9551,"preClose":0.9551,"latestTime":"18:37 EST","volume":238,"amount":227.8616,"timestamp":1734737824276},"delay":0,"floatShares":40900012,"shares":54518165,"eps":0.064745,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0429,"latestTime":"12-20 15:59:59 EST","open":0.99,"high":0.99,"low":0.9501,"amount":319700.628654,"amplitude":0.03998,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.064745,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1509595200000,"adjPreClose":0.998,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.99,"preClose":0.998,"latestTime":"09:26 EST","volume":1805,"amount":1787.018879,"timestamp":1734704780733},"postHourTrading":{"tag":"盘后","latestPrice":0.9551,"preClose":0.9551,"latestTime":"18:37 EST","volume":238,"amount":227.8616,"timestamp":1734737824276},"volumeRatio":1.1926769096491412,"impliedVol":0.0019,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/SPRO","defaultTab":"news","newsList":[{"id":"2486035811","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486035811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486035811?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:08","pubTimestamp":1732547336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时08分,Spero Therapeutics, Inc.股票出现波动,股价大幅下跌5.17%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.87%。其相关个股中,Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为96.77%、92.96%、55.10%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为55.45%、48.93%、47.19%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230856971a8660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230856971a8660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2485076298","title":"Spero Therapeutics, Inc.2024财年第三财季实现净利润-17.15百万美元,同比减少434.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485076298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485076298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291408,"startTime":"0","endTime":"0","summary":"11月23日,Spero Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-17.15百万美元,同比减少434.27%;其中营业收入为7.82百万美元,同比减少66.55%,每股基本收益为-0.32美元。机构评级:截至2024年11月23日,当前有2家机构对Spero Therapeutics, Inc.目标价做出预测,其中目标均价为5.00美元,其中最低目标价为5.00美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2485912139","title":"Spero Therapeutics, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485912139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485912139?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:05","pubTimestamp":1732129545,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时05分,Spero Therapeutics, Inc.股票出现异动,股价急速拉升5.12%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大,Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃,换手率分别为1845.78%、1318.25%、952.81%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.,振幅分别为185.64%、169.09%、136.94%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2484041976","title":"Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484041976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484041976?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:19","pubTimestamp":1731953962,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时19分,Spero Therapeutics, Inc.股票出现波动,股价快速跳水5.08%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2483738405","title":"Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738405?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:13","pubTimestamp":1731604382,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时13分,Spero Therapeutics, Inc.股票出现异动,股价大幅跳水6.11%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3406.72%、3163.20%、360.18%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、86.36%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2481673483","title":"Spero Therapeutics Inc 预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481673483","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481673483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:49","pubTimestamp":1731080962,"startTime":"0","endTime":"0","summary":" * Spero Therapeutics Inc 预计将在 11 月 14 日公布截至 0001 年 1 月 1 日的季度收入报告。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的2547万美元下降69.9%,至766.7万美元。* LSEG 分析师对 Spero Therapeutics Inc 的平均预期是每股亏损 36 美分。* 华尔街对 Spero Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元,高于其上次收盘价 1.31 美元。11月8日 - 上一季度业绩。除非另有说明,所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2480858040","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.93%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480858040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480858040?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:37","pubTimestamp":1730734628,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时37分,Spero Therapeutics, Inc.股票出现异动,股价大幅上涨5.93%。截至发稿,该股报1.25美元/股,成交量9.0553万股,换手率0.17%,振幅7.63%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为263.35%、260.56%、66.87%,振幅较大的相关个股有In8Bio, Inc.、Kazia Therapeutics Limited、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为45.39%、39.13%、31.90%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104233708971a4335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104233708971a4335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2479355800","title":"Spero Therapeutics, Inc.盘中异动 大幅跳水5.43%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479355800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479355800?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:06","pubTimestamp":1730383567,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时06分,Spero Therapeutics, Inc.股票出现波动,股价快速下跌5.43%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.83%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220607ab8bb886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220607ab8bb886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2479347785","title":"Spero Therapeutics, Inc.盘中异动 快速跳水19.85%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479347785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479347785?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295106,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分,Spero Therapeutics, Inc.股票出现异动,股价急速下跌19.85%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1736.42%、98.93%、15.89%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.,振幅分别为22.66%、11.49%、10.79%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314795bd8df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314795bd8df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2478953969","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.56%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478953969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478953969?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:02","pubTimestamp":1729872165,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时02分,Spero Therapeutics, Inc.股票出现异动,股价快速上涨5.56%。截至发稿,该股报1.33美元/股,成交量21.1513万股,换手率0.39%,振幅2.38%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为816.21%、743.25%、224.31%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.,振幅分别为91.58%、90.60%、85.14%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000245a1ead8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026000245a1ead8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2476248518","title":"Spero Therapeutics, Inc.盘中异动 下午盘快速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476248518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476248518?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:33","pubTimestamp":1729186408,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时33分,Spero Therapeutics, Inc.股票出现波动,股价快速上涨5.24%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101801332998e3d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101801332998e3d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2473201420","title":"Spero Therapeutics, Inc.盘中异动 早盘大幅跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473201420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473201420?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:31","pubTimestamp":1728394299,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时31分,Spero Therapeutics, Inc.股票出现波动,股价大幅跳水5.38%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bio-Path Holdings, Inc.、Virios Therapeutics, Inc.涨幅较大,Virios Therapeutics, Inc.、Aditxt, Inc.、Bio-Path Holdings, Inc.较为活跃,换手率分别为2707.00%、1660.81%、1117.40%,振幅较大的相关个股有Virios Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Entero Therapeutics Inc.,振幅分别为14.29%、13.48%、12.02%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082131409719ef4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082131409719ef4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2470803863","title":"Spero Therapeutics, Inc.盘中异动 早盘急速上涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470803863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470803863?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:19","pubTimestamp":1727450347,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时19分,Spero Therapeutics, Inc.股票出现波动,股价快速上涨5.47%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为3891.00%、211.89%、122.97%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为167.75%、61.38%、51.69%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231907ab66870f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231907ab66870f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2460680055","title":"Spero Therapeutics, Inc.盘中异动 急速上涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460680055","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460680055?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:19","pubTimestamp":1724080786,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日23时19分,Spero Therapeutics, Inc.股票出现波动,股价急速拉升5.04%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为6342.24%、3003.36%、934.40%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为405.90%、220.18%、93.47%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819231946971992bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819231946971992bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2458069291","title":"Spero Therapeutics, Inc.2024财年第二财季实现净利润-17.86百万美元,同比减少49.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458069291","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458069291?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:09","pubTimestamp":1723392568,"startTime":"0","endTime":"0","summary":"8月12日,Spero Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-17.86百万美元,同比减少49.96%;其中营业收入为6.02百万美元,同比增加663.96%,每股基本收益为-0.33美元。机构评级:截至2024年8月12日,当前有2家机构对Spero Therapeutics, Inc.目标价做出预测,其中目标均价为7.50美元,其中最低目标价为7.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009339f22255b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009339f22255b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2457076237","title":"TD Cowen:上调Spero Therapeutics(SPRO.US)评级,由持有调整至买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457076237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457076237?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:55","pubTimestamp":1722963343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","SPRO","BK4566","LENZ","BK4207","TD","BK4585"],"gpt_icon":0},{"id":"2457023647","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023647","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023647?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:41","pubTimestamp":1722951691,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时41分,Spero Therapeutics, Inc.股票出现波动,股价大幅下挫5.22%。截至发稿,该股报1.27美元/股,成交量10.0056万股,换手率0.19%,振幅7.46%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为905.37%、505.09%、230.95%,振幅较大的相关个股有Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Actinium Pharmaceuticals, Inc. ,振幅分别为135.14%、29.11%、27.81%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214131968245e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214131968245e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2454072768","title":"Spero Therapeutics, Inc.盘中异动 下午盘快速上涨6.52%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454072768","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454072768?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:09","pubTimestamp":1721927347,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日01时09分,Spero Therapeutics, Inc.股票出现异动,股价急速拉升6.52%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃,换手率分别为4704.10%、559.34%、280.64%,振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.,振幅分别为152.48%、132.26%、98.60%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010907af94232d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010907af94232d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2452745913","title":"Spero Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452745913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452745913?lang=zh_cn&edition=full","pubTime":"2024-07-19 04:00","pubTimestamp":1721332830,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日04时00分,Spero Therapeutics, Inc.股票出现波动,股价快速下跌5.41%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.91%。其相关个股中,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为3563.03%、2836.27%、1350.67%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、90.54%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719040030941f8694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719040030941f8694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2452494913","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452494913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452494913?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:36","pubTimestamp":1721154976,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时36分,Spero Therapeutics, Inc.股票出现波动,股价大幅上涨5.19%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr,是一种口服碳青霉烯类抗生素,用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023617aef9f858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023617aef9f858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sperotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1074},{"period":"1month","weight":-0.2041},{"period":"3month","weight":-0.2819},{"period":"6month","weight":-0.3028},{"period":"1year","weight":-0.2977},{"period":"ytd","weight":-0.3503}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,该公司相信这将开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。该公司相信,如果成功地开发和批准该新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.068144},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.038645},{"month":3,"riseRate":0.428571,"avgChangeRate":0.002566},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.028483},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.12624},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.016403},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.042117},{"month":8,"riseRate":0.285714,"avgChangeRate":0.04487},{"month":9,"riseRate":0.428571,"avgChangeRate":0.176126},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.040426},{"month":11,"riseRate":0.571429,"avgChangeRate":0.022543},{"month":12,"riseRate":0.375,"avgChangeRate":-0.01853}],"exchange":"NASDAQ","name":"Spero Therapeutics Inc.","nameEN":"Spero Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spero Therapeutics Inc.,SPRO,Spero Therapeutics Inc.股票,Spero Therapeutics Inc.股票老虎,Spero Therapeutics Inc.股票老虎国际,Spero Therapeutics Inc.行情,Spero Therapeutics Inc.股票行情,Spero Therapeutics Inc.股价,Spero Therapeutics Inc.股市,Spero Therapeutics Inc.股票价格,Spero Therapeutics Inc.股票交易,Spero Therapeutics Inc.股票购买,Spero Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}